RUA BIOSCIENCES ( Hikurangi)

[kiora]

"The Next Big Addiction Treatment"
https://www.nytimes.com/2022/03/31/w...n-therapy.html

[Sideshow Bob]

https://www.nzx.com/announcements/427120

HY results.

Still a hard road. Ignoring all their "strategic expansion" & " notable growth initiatives"......have to look at 'revenue from contracts with customers' and for the 6 months was $16,988.

That isn't $16,988 ('000s). Just $16,988.00.

Price down 4.4% and the ski slope continues.

[shareman]

https://www.nzx.com/announcements/427120

HY results.

Still a hard road. Ignoring all their "strategic expansion" & " notable growth initiatives"......have to look at 'revenue from contracts with customers' and for the 6 months was $16,988.

That isn't $16,988 ('000s). Just $16,988.00.

Price down 4.4% and the ski slope continues.

That's better than GFI.NZX, at least their auditors haven't quit on them

[kiwical]

RUA gains approval to expand their research into magic mushrooms. Maybe something will come of that given that cannabis doesn't seem to be doing much amongst the NZ companies.

https://www.ruabio.com/news/psilocyb...room-programme

[Toddy]

Is it full moon already.

When is the next cap raise for the faithful.

[Sideshow Bob]

Hasn't helped their share price.

Maybe their 1st exports to Ko Phangan??

[Toddy]

Trying to make sense of this Company.

Revenue for the 6 months end Dec $16,988.00.
Big legal bills coming up due to Cann pulling out.
Goodwill is massive at 2.2m. Not sure if the rules of having this on your balance sheet when you don't earn revenue.

Zero financial forecast released with the interim accounts.

Maybe Shane Jones likes mushrooms. But based on the Governments books at the moment I'm guessing that train has already left the station.

[nztx]

Trying to make sense of this Company.

Revenue for the 6 months end Dec $16,988.00.
Big legal bills coming up due to Cann pulling out.
Goodwill is massive at 2.2m. Not sure if the rules of having this on your balance sheet when you don't earn revenue.

Zero financial forecast released with the interim accounts.

Maybe Shane Jones likes mushrooms. But based on the Governments books at the moment I'm guessing that train has already left the station.

Their mates over at CBD don't appear to be fairing much better - another load of Borrowing Notes & scraps going on out back


At least this one appears to be exercising a more conservative approach than CBD .. Recognising impearments, no large scale borrowings, no borrowing to buy a competitor with a bucket of cash on the target's books to rescue things for a mere 6 months or so.

On that basis RUA seems to score a few more brownie points .. even if getting the stuff out in any quantity
appears to be problematic with other challenges added in like chasing a wallaby around the paddock from a great distance after it got off the short leash

[Sideshow Bob]

Just reminding the market they are there and still working away.....

https://www.nzx.com/announcements/428832

Tairawhiti, New Zealand – Rua Bioscience is continuing to expand its offering in Australia, one of the largest medicinal cannabis markets in the world.
With company licences and distribution channels established in 2023, Rua successfully launched into this key market last September with a dried flower product.
It has now extended the range with the introduction of full spectrum oil products and liquid vaporisation cartridges.
“Australia has always been an important focus for us,” said CEO Paul Naske.
“Now that we have a broader range of products available in Australia, we are well positioned to develop a strong sales presence and build the Rua brand there.”
This push into Australia is supported by Rua’s recent appointment of their first Australian-based Chief of Sales and Marketing, to drive growth and market share.
“Rua’s strategy is to commercialise our unique genetics on a global scale,” added Mr Naske. “In the coming months, we’re aiming to launch a range of medicinal cannabis products using our New Zealand genetics into the Australian market.”